RxDoctor Payments Data

Regina Simpson, NP

Family · Duffield, VANPI 1891202628

Payments from drug & device makers

$982in general payments, 2019–2025

Across 53 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$344
  • Novo Nordisk$145
  • AbbVie$104
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$93
  • Pfizer$65
  • Abbott$55
  • plus $176 from 8 others

What the payments were for

  • Food & beverage$982100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$982 in reported general payments places this provider in the 70th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$24,749
Medicare patients
82
Services billed
597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,756
Albuterol Sulfate HfaAlbuterol Sulfate74$2,148
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen54$1,284
Oxycodone Hcl40$904
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$826
Gabapentin53$462
Hydroxyzine Hcl21$331
Mirtazapine17$295
Clonazepam16$281
Levothyroxine Sodium23$266
Cefdinir20$256
Azithromycin58$237
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide11$236
Ondansetron OdtOndansetron12$206
Bupropion XlBupropion Hcl11$195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$13$8,75614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,332 family providers in Virginia.

Other family in Duffield

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →